Holen Sie sich die Stockscreener-App
31.85
1.88%
-0.61
Handel nachbörslich:
31.85
Anaptysbio Inc Aktie (ANAB) Neueste Nachrichten
Can AnaptysBio Inc. stock beat market expectations this quarterJuly 2025 Macro Moves & Safe Entry Momentum Tips - newser.com
AnaptysBio, Inc. Updates on ANB033 and Corporate Developments - TradingView
Barclays Initiates Coverage on AnaptysBio (NASDAQ:ANAB) - MarketBeat
AnaptysBio stock price target raised to $72 from $57 at Piper Sandler - Investing.com
How AnaptysBio Inc. stock reacts to job market dataQuarterly Portfolio Report & Expert Approved Momentum Ideas - newser.com
Is AnaptysBio Inc. stock positioned well for digital economyMarket Risk Analysis & Growth Focused Entry Reports - newser.com
Rosnilimab phase 2b rheumatoid arthritis data to be presented at ACR - Investing.com Nigeria
Anaptys Announces Late-Breaking Oral Presentation of Complete Phase 2b Data for Rosnilimab in Rheumatoid Arthritis at Upcoming ACR Convergence 2025 - MarketScreener
Why AnaptysBio Inc. stock could outperform in 2025July 2025 Reactions & Technical Pattern Alert System - newser.com
Should you wait for a breakout in AnaptysBio Inc.Weekly Gains Report & Verified Momentum Stock Alerts - newser.com
AnaptysBio Announces Late-Breaking Presentation of Phase 2b Trial Data for Rosnilimab in Rheumatoid Arthritis at ACR Convergence 2025 - Quiver Quantitative
Anaptys Announces Late-Breaking Oral Presentation of - GlobeNewswire
AnaptysBio to present rosnilimab rheumatoid arthritis data at ACR meeting - StreetInsider
6‑Month JAK‑like Efficacy: Anaptys' Rosnilimab Phase 2b Accepted for ACR Late‑Breaking Oral Presentation - Stock Titan
Barclays Initiates Coverage on AnaptysBio (ANAB) with Overweight Rating | ANAB Stock News - GuruFocus
Barclays Initiates AnaptysBio at Overweight With $78 Price Target - MarketScreener
AnaptysBio Inc. stock prediction for this weekQuarterly Portfolio Report & Expert Approved Momentum Ideas - newser.com
Barclays initiates AnaptysBio stock with Overweight rating on rosnilimab potential - Investing.com Canada
What drives AnaptysBio Inc stock priceMarket Depth Overview & Small Investment Capital Tips - earlytimes.in
How moving averages guide AnaptysBio Inc. tradingGold Moves & Risk Managed Investment Signals - newser.com
Q3 EPS Estimates for AnaptysBio Lifted by Leerink Partnrs - MarketBeat
Can AnaptysBio Inc. (AN6) stock resist broad market declinesWeekly Stock Recap & Reliable Intraday Trade Alerts - newser.com
Will AnaptysBio Inc. (AN6) stock outperform benchmarks2025 Top Decliners & Free Verified High Yield Trade Plans - newser.com
AnaptysBio splits operations into two companies - MSN
AnaptysBio's (ANAB) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
AnaptysBio, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
AnaptysBio, Inc. (NASDAQ:ANAB) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
HighMark Wealth Management LLC Raises Stock Position in AnaptysBio, Inc. $ANAB - MarketBeat
Leerink Partnrs Decreases Earnings Estimates for AnaptysBio - MarketBeat
Custom strategy builders for tracking AnaptysBio Inc.Market Sentiment Report & Growth Focused Stock Reports - newser.com
Is AnaptysBio Inc. reversing from oversold territoryWeekly Trade Review & Daily Chart Pattern Signals - newser.com
Applying sector rotation models to AnaptysBio Inc.2025 Bull vs Bear & Reliable Price Breakout Signals - newser.com
Chart overlay techniques for tracking AnaptysBio Inc.July 2025 Short Interest & Safe Capital Growth Stock Tips - newser.com
Is AnaptysBio Inc. (AN6) stock good for long term investingEarnings Miss & Breakout Confirmation Alerts - newser.com
AnaptysBio (NASDAQ:ANAB) Stock Price Down 5.9%Time to Sell? - MarketBeat
HC Wainwright Analysts Cut Earnings Estimates for AnaptysBio - MarketBeat
Biggest stock movers today: UUUU, FLY, and more - MSN
AnaptysBio (NASDAQ:ANAB) Trading 8.9% Higher After Analyst Upgrade - Defense World
AnaptysBio, Inc. Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo
AnaptysBio (NASDAQ:ANAB) Shares Up 8.9% on Analyst Upgrade - MarketBeat
AnaptysBio Charts Path To Split Into Two Public Companies By 2026 - Sahm
AnaptysBio (NASDAQ:ANAB) Price Target Raised to $59.00 at HC Wainwright - Defense World
AnaptysBio (NASDAQ:ANAB) Shares Gap Up on Analyst Upgrade - Defense World
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):